Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Other financing activities (2024 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Other financing activities came in at $94711.0 in Q1 2026, down 96.21% on a QoQ basis from $2.5 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Other financing activities (2024 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 4 years of Other financing activities data on file, last reported at $94711.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $94711.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, down 9.24% from the prior year.
  • Other financing activities retreated to $94711.0 in Q1 2026, from $2.5 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.6 million in Q4 2024 to a low of -$13.6 million in Q4 2022.
  • A 4-year average of -$1.0 million and a median of $545587.5 in 2024 frame the typical range for Other financing activities.
  • The widest YoY moves for Other financing activities: up 588.14% in 2025, down 31.44% in 2025.
  • Tracing CNTN's Other financing activities over 4 years: stood at -$13.6 million in 2022, then soared by 126.77% to $3.6 million in 2024, then plunged by 31.44% to $2.5 million in 2025, then tumbled by 96.21% to $94711.0 in 2026.
  • The last three Other financing activities figures came in at $94711.0 (Q1 2026), $2.5 million (Q4 2025), and $952725.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68,981.00
Mar 31, 2026 3.56 Mn
Dec 31, 2025 6.26 Mn
Sep 30, 2025 1.23 Mn
Dec 31, 2024 2.02 Mn